| Literature DB >> 25853317 |
Carlos Alberto Huerta Aguilar1, Adriana Berenice Pérez Jiménez2, Antonio Romero Silva3, Navneet Kaur4, Pandiyan Thangarasu5, Jorge Manuel Vázquez Ramos6, Narinder Singh7.
Abstract
Organic nanoparticles (ONPs) ofEntities:
Mesh:
Substances:
Year: 2015 PMID: 25853317 PMCID: PMC6272726 DOI: 10.3390/molecules20046002
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1(a) Formation of α-lipoic acid ONPs; (b) preparation of ONPs/Ag and ONPs/Au.
Figure 2Transmission Electron Microscope micrographs: (a) ONPs; (b) ONPs/Ag (ratio 10:1); (c) ONPs/Au (ratio 10:1); (d) Ag NPs and (e) Au NPs.
Figure 3Energy Dispersive Spectrometry analysis: (a) ONPs, (b) ONPs/Ag (ratio 10:1), (c) ONPs/Au (ratio 10:1).
Figure 4Characterization of ONPs; (a) visible appearance: (i) ONPs; (ii) ONPs/Ag and (iii) ONPs/Au; (b) UV-Visible profile of lipoic acid-ONPs.
Figure 5Antibacterial effects: Bacterial survival (%) after treatment with different NPs (0.2 mM).
Minimal Inhibitory concentration of different bacteria treated NPs.
| Inhibitor | Minimal Inhibitory Concentration (MIC) [ | |||
|---|---|---|---|---|
| Gram (+) | Gram (−) | |||
|
|
|
|
| |
|
| 0.31 ± 0.04 | 0.39 ± 0.03 | 0.39 ± 0.05 | 0.39 ± 0.04 |
|
| 0.26 ± 0.05 | 0.26 ± 0.05 | 0.22 ± 0.02 | 0.22 ± 0.03 |
|
| 0.39 ± 0.11 | 0.44 ± 0.02 | 0.44 ± 0.09 | 0.44 ± 0..04 |
|
| 0.17 ± 0.04 | 0.17 ± 0.03 | 0.13 ± 0.01 | 0.13 ± 0.05 |
|
| 1.76 ± 0.05 | 1.82 ± 0.05 | 1.28 ± 0.07 | 1.12 ± 0.09 |
Figure 6Comparative bacterial growth inhibition (1) Salmonella typhi and (2) Staphylococcus aureus: after treatment (a) Control; (b) AgNPs (0.02 mM); (c) ONPs (0.2 mM); (d) ONPs/Ag (0.2 mM).
Figure 7Minimal inhibitory concentration (MIC) of bacteria treated with different NPs.
Figure 8Disk diffusion test: (a) Staphylococcus aureus; (b) Salmonella typhi.
Antibacterial parameters for different bacteria treated with different NPs.
| Inhibition Zone Diameter (mm) * | |||||
|---|---|---|---|---|---|
| Material | Concentration [ |
|
|
|
|
| ONPs | 5.0 | NP | NP | NP | NP |
| ONPs/Ag | 5.0 | 7.0 ± 0.16 | 7.6 ± 0.12 | 9.3 ± 0.13 | 9.0 ± 0.10 |
| ONPs/Ag | 0.5 | 7.0 ± 0.11 | 8 ± 0.09 | 9.7 ± 0.12 | 9.3 ± 0.08 |
| ONPs/Au | 5.0 | 12.0 ± 0.21 | 11 ± 0.10 | 13 ± 0.14 | 13 ± 0.11 |
| Ag-NPs | 5.0 | - | - | - | - |
| Au-NPs | 5.0 | - | - | - | - |
* Inhibition zone diameter includes the paper disc diameter (6.0 mm) which contained stock solution (5.0 mM).
Figure 9SEM images of bacterial strains after treatment with NPs. (a) Bacillus cereus with ONPs; (b) Bacillus cereus with ONPs/Ag; (c) Bacillus cereus with Ag NPs; (d) Salmonella typhi with ONPs; (e) Salmonella typhi with ONPs/Ag and (f) Salmonella typhi with AgNPs.
Frontier molecular orbital (FMOs) for LA and its decorated with Ag or Au.
| Molecular Orbital | Energy (eV) | ||
|---|---|---|---|
| LA | Ag-LA | Au-LA | |
| LUMO+3 | 0.001 | 0.490 | −0.288 |
| LUMO+2 | −0.027 | 0.005 | −0.620 |
| LUMO+1 | −0.310 | −0.599 | −2.637 |
| LUMO | −1.361 | −1.551 | −3.371 |
| ΔE(HOMO-LUMO) | 4.446 | 4.136 | 2.433 |
| HOMO | −5.807 | −5.687 | −5.804 |
|
| |||
| HOMO-1 | −7.758 | −5.959 | −6.626 |
| HOMO-2 | −8.073 | −6.476 | −7.227 |
| HOMO-3 | −8.696 | −7.456 | −7.978 |
Figure 10Optimized structures of LA (a) and its forms decorated with Ag (b) or Au (c).
Figure 11Density of states for LA, and its doping with metal atoms: (a) LA-ONPs; (b) Ag doped (1.0%) with LA-ONPs and (c) Au doped (1.0%) LA-ONPs calculated through B3LYP/6-311G(d,p) for LA and B3LYP/LANL2DZ for Ag/Au-LA.
Figure 12Frontier molecular orbitals: (a) LA; (b) LA/Ag.